NCT00736801View on ClinicalTrials.gov

Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

April 30, 2007

Conditions
Allergic Asthma
Interventions
DRUG

Salmeterol and Salmeterol / Fluticasone

Patients inhale salmeterol for 2 weeks, followed by an inhalation of both salmeterol and fluticasone for 2 weeks.

Trial Locations (1)

18057

University of Rostock, Rostock

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Rostock

OTHER